QUANTITATIVE OF PLATELETS AGAINST THE BACKGROUND OF ANTI-VIRUS THERAPY IN CHRONIC HEPATITIS WITH HCV ETIOLOGY.
Liver disease leads to impaired blood clotting mainly due to malfunction of platelet adhesion and aggregation. [7]. This dysfunction is related to the activity of specific enzymes and transaminases in the liver [3,6]. An increase in the activity of transaminases is a sign of cytolytic syndrome, in which a decrease in platelet aggregation is observed [1.].
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-11-21
- DOI
- https://doi.org/10.5281/zenodo.14195515
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00